{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T10:07:00Z","timestamp":1771927620304,"version":"3.50.1"},"reference-count":10,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>RAC2-related immunodeficiency is a rare inborn error of immunity with a broad clinical spectrum ranging from neonatal severe combined immunodeficiency to atypical combined immunodeficiency diagnosed later in life. We describe two unrelated French-Canadian patients carrying a rare, homozygous RAC2 variant (c.202C&amp;gt;T; p.R68W), both presenting with combined immunodeficiency. The first patient developed recurrent bacterial respiratory infections and early bronchiectasis that initially responded to immunoglobulin replacement therapy. She subsequently experienced severe, treatment-refractory cutaneous viral infections. In adulthood, she developed gynecologic and anal neoplasms associated with chronic viral disease, requiring long-term multidisciplinary management. The second patient presented in early childhood with recurrent respiratory infections, marked lymphoproliferation, and generalized lymphadenopathy. He then developed kidney dysfunction due to light-chain deposition disease. Management included immunoglobulin therapy, and ultimately hematopoietic cell transplantation (HCT), after which he achieved sustained clinical improvement. Genetic testing identified the same homozygous p.R68W substitution in both patients. Despite significantly reduced RAC2 protein expression, patient-derived cells exhibited increased effector signaling in the homozygous state, producing a phenotype that phenocopies dominant gain-of-function RAC2 variants. Functional hyperactivation was not observed in heterozygous cells, supporting a dosage-dependent mechanism. These cases expand the clinical and functional spectrum of RAC2 deficiency and have immediate implications for clinical care. Persistent viral disease with oncogenic complications, bronchiectasis, lymphoproliferation, or progressive organ involvement should prompt consideration of RAC2 testing even beyond infancy. From a diagnostic standpoint, reliance on expression alone may be misleading; incorporating targeted signaling assays is essential for accurate variant interpretation. Therapeutically, HCT can be effective in progressive disease with organ damage, while others may require long-term medical management of chronic viral complications. Recognizing this rare, homozygous p.R68W variant and its functional consequences supports a precision-diagnosis approach to RAC2-related immunodeficiency and refines surveillance and treatment strategies for affected patients.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1723142","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T06:44:34Z","timestamp":1769582674000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Characterization of a RAC2 R68W homozygous activating mutation causing combined immune deficiency"],"prefix":"10.3389","volume":"17","author":[{"given":"Al\u00e9handra","family":"Desjardins","sequence":"first","affiliation":[{"name":"Center for Immunity, Inflammation and Infectious Diseases, Montreal Clinical Research Institute (IRCM)","place":["Montreal, QC, Canada"]},{"name":"Department of Microbiology, Infectious Diseases and Immunology, Universit\u00e9 de Montr\u00e9al","place":["Montreal, QC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Marois","sequence":"additional","affiliation":[{"name":"Center for Immunity, Inflammation and Infectious Diseases, Montreal Clinical Research Institute (IRCM)","place":["Montreal, QC, Canada"]},{"name":"Division of Allergy and Immunology, Department of Medicine, CHU de Qu\u00e9bec, Universit\u00e9 Laval","place":["Quebec, QC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1gnes","family":"Donk\u00f3","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)","place":["Bethesda, MD, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilhem","family":"Cros","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Infectious Diseases and Immunology, Universit\u00e9 de Montr\u00e9al","place":["Montreal, QC, Canada"]},{"name":"Division of Allergy and Clinical Immunology, Department of Medicine, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM)","place":["Montreal, QC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc-Antoine","family":"B\u00e9dard","sequence":"additional","affiliation":[{"name":"Division of Allergy and Immunology, Department of Medicine, CHU de Qu\u00e9bec, Universit\u00e9 Laval","place":["Quebec, QC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Lorna","family":"Paul","sequence":"additional","affiliation":[{"name":"Center for Immunity, Inflammation and Infectious Diseases, Montreal Clinical Research Institute (IRCM)","place":["Montreal, QC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy P.","family":"Hsu","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)","place":["Bethesda, MD, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Darbinian","sequence":"additional","affiliation":[{"name":"Center for Immunity, Inflammation and Infectious Diseases, Montreal Clinical Research Institute (IRCM)","place":["Montreal, QC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9raldine","family":"Gosse","sequence":"additional","affiliation":[{"name":"Center for Immunity, Inflammation and Infectious Diseases, Montreal Clinical Research Institute (IRCM)","place":["Montreal, QC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas L.","family":"Leto","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)","place":["Bethesda, MD, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"Chapdelaine","sequence":"additional","affiliation":[{"name":"Center for Immunity, Inflammation and Infectious Diseases, Montreal Clinical Research Institute (IRCM)","place":["Montreal, QC, Canada"]},{"name":"Division of Allergy and Clinical Immunology, Department of Medicine, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM)","place":["Montreal, QC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"Mass\u00e9","sequence":"additional","affiliation":[{"name":"Center for Immunity, Inflammation and Infectious Diseases, Montreal Clinical Research Institute (IRCM)","place":["Montreal, QC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Fernandez","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Infectious Diseases and Immunology, Universit\u00e9 de Montr\u00e9al","place":["Montreal, QC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabien","family":"Touzot","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Infectious Diseases and Immunology, Universit\u00e9 de Montr\u00e9al","place":["Montreal, QC, Canada"]},{"name":"Division of Pediatric Immunology and Rheumatology, Department of Pediatrics, CHU Sainte-Justine, Universit\u00e9 de Montr\u00e9al","place":["Montreal, QC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herawaty","family":"Sebajang","sequence":"additional","affiliation":[{"name":"Department of Surgery, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM)","place":["Montreal, QC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia Liana","family":"Falcone","sequence":"additional","affiliation":[{"name":"Center for Immunity, Inflammation and Infectious Diseases, Montreal Clinical Research Institute (IRCM)","place":["Montreal, QC, Canada"]},{"name":"Department of Microbiology, Infectious Diseases and Immunology, Universit\u00e9 de Montr\u00e9al","place":["Montreal, QC, Canada"]},{"name":"Department of Medicine, Universit\u00e9 de Montr\u00e9al","place":["Montreal, QC, Canada"]},{"name":"Division of Microbiology and Infectious Diseases, Department of Medicine, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM)","place":["Montreal, QC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022098","article-title":"Clinical and functional spectrum of RAC2-related immunodeficiency","volume":"143","author":"Donko","year":"2024","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-886028","article-title":"Dominant activating RAC2 mutation with lymphopenia, immunodeficiency, and cytoskeletal defects","volume":"133","author":"Hsu","year":"2019","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/j.jaci.2019.01.001","article-title":"A monoallelic activating mutation in RAC2 resulting in a combined immunodeficiency","volume":"143","author":"Lougaris","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"108248","DOI":"10.1016\/j.clim.2019.108248","article-title":"A dominant activating RAC2 variant associated with immunodeficiency and pulmonary disease","volume":"212","author":"Smits","year":"2020","journal-title":"Clin Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2019.05.003","article-title":"Heterozygous activating mutation in RAC2 causes infantile-onset combined immunodeficiency with susceptibility to viral infections","volume":"205","author":"Sharapova","year":"2019","journal-title":"Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.230250","article-title":"A gain-of-function RAC2 mutation is associated with bone-marrow hypoplasia and an autosomal dominant form of severe combined immunodeficiency","volume":"106","author":"Chantal","year":"2021","journal-title":"Haematologica"},{"key":"B7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/978-1-62703-845-4_6","article-title":"Rho family and Rap GTPase activation assays","volume":"1124","author":"Jennings","year":"2014","journal-title":"Methods Mol Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000644","article-title":"CD137 deficiency causes immune dysregulation with predisposition to lymphomagenesis","volume":"134","author":"Somekh","year":"2019","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.jaci.2019.03.002","article-title":"Immunodeficiency and EBV-induced lymphoproliferation caused by 4-1BB deficiency","volume":"144","author":"Alosaimi","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-021-01378-8","article-title":"EBMT\/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity","volume":"56","author":"Lankester","year":"2021","journal-title":"Bone Marrow Transpl"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1723142\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:14:21Z","timestamp":1771924461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1723142\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":10,"alternative-id":["10.3389\/fimmu.2026.1723142"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1723142","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"article-number":"1723142"}}